Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  MUMBAI STOCK EXCHANGE  >  Indoco Remedies Ltd    532612   INE873D01024

INDOCO REMEDIES LTD

(532612)
  Report  
 SummaryChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Mumbai Stock Exchange
11/28/2019 11/29/2019 12/02/2019 12/03/2019 12/04/2019 Date
164.95 162.55 156.6 156.7 163.4 Last
1148 3257 1315 5112 1694 Volume
-3.26% -1.45% -3.66% +0.06% +4.28% Change
Financials (INR)
Sales 2020 11 323 M
EBIT 2020 -
Net income 2020 305 M
Debt 2020 -
Yield 2020 0,43%
Sales 2021 13 635 M
EBIT 2021 -
Net income 2021 975 M
Debt 2021 -
Yield 2021 0,61%
P/E ratio 2020 49,6x
P/E ratio 2021 14,2x
Capi. / Sales2020 1,33x
Capi. / Sales2021 1,11x
Capitalization 15 090 M
More Financials
Company
Indoco Remedies Limited is an India-based company, which is engaged in the manufacture of pharmaceutical products. The Company primarily manufactures and markets Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). The Company's geographical segments include India and... 
Sector
Pharmaceuticals
Calendar
01/24Earnings Release
More about the company
Latest news on INDOCO REMEDIES LTD
10/21INDOCO REMEDIES : Clinical Research Organisation receives zero 483s from USFDA
AQ
10/17INDOCO REMEDIES : successfully concludes USFDA inspection at Goa Plant II
AQ
09/23INDOCO REMEDIES : successfully completes UK-MHRA inspection at Goa Plant II
AQ
09/16INDOCO REMEDIES : UK-MHRA reinstates full GMP status for Indoco's Goa Plant I
AQ
More news
News in other languages on INDOCO REMEDIES LTD

- No features available -

More news
Sector news : Pharmaceuticals - NEC
02:34pUK bribery investigation adds to Glencore's legal headaches
RE
02:27pBILL GATES : Gates Foundation CEO Sue Desmond-Hellman to step down after five ye..
RE
01:00pROCHE : family adds new members to shareholder group to ensure continuity
RE
12:56pROCHE : FDA Approves Marketing of Roche Diagnostics MRSA Diagnostic Test
DJ
10:36aDAVIDSON KEMPNER CAPITAL MANAGEMENT : Form 8.3 - Allergan Plc
DJ
More sector news : Pharmaceuticals - NEC
Chart INDOCO REMEDIES LTD
Duration : Period :
Indoco Remedies Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
 
Mean consensus -
Number of Analysts
Average target price
Last Close Price 163,75  
Spread / Highest target -
Spread / Average Target -
Spread / Lowest Target -
EPS Revisions
Managers
NameTitle
Sundeep Vasant Bambolkar Joint Managing Director & Executive Director
Aditi Kare Panandikar Joint Managing Director & Executive Director
Suresh Govind Kare Executive Chairman
Mandar Borkar Chief Financial Officer
Kavita lnamdar President-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
INDOCO REMEDIES LTD-24.70%211
JOHNSON & JOHNSON6.28%366 830
ROCHE HOLDING AG23.25%261 977
MERCK AND COMPANY16.05%225 752
PFIZER-12.83%211 071
NOVARTIS20.40%206 488